Automated Biopsy Guns and Needles Market
Automatic biopsy guns and needles are devices that use a disposable needle to extract high-qualit ... Read More
This report contains market size and forecasts of Point of Care Diagnostic and Testing in Global, including the following market information:
Global Point of Care Diagnostic and Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Point of Care Diagnostic and Testing market was valued at 26410 million in 2021 and is projected to reach US$ 47710 million by 2028, at a CAGR of 8.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Point of Care Diagnostic and Testing include F. Hoffmann-La Roche, Qiagen, Danaher, Becton Dickinson and Company, Biomerieux, Siemens Healthcare, Zoetis, Abbott and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Point of Care Diagnostic and Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Point of Care Diagnostic and Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Point of Care Diagnostic and Testing Market Segment Percentages, by Type, 2021 (%)
Device
Consumables
Others
Global Point of Care Diagnostic and Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Point of Care Diagnostic and Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Home
Others
Global Point of Care Diagnostic and Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Point of Care Diagnostic and Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Point of Care Diagnostic and Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Point of Care Diagnostic and Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche
Qiagen
Danaher
Becton Dickinson and Company
Biomerieux
Siemens Healthcare
Zoetis
Abbott
Bayer
Johnson and Johnson
Nova Biomedical
Trividia Health
Quidel Corporation
Trinity Biotech
Sekisui Diagnostics
Orasure Technologies
Nipro
Spectral Medical
Automatic biopsy guns and needles are devices that use a disposable needle to extract high-qualit ... Read More
An ultrasound-guided breast biopsy uses sound waves to help locate a lump or abnormality and remo ... Read More
Needle-based biopsy guns are handheld devices, which include a motor assembly attached to a biops ... Read More
Capturing of patient’s tooth or gum areas using an X-Ray based camera is called an intraoral ca ... Read More